Everyday Health

What People of Color Should Know About Joining an Atopic Dermatitis Clinical Trial

Learn why representation in atopic dermatitis clinical trials matters for people of color, as well as the benefits, risks, ...

AAD: Subcutaneous amlitelimab aids atopic dermatitis outcomes through week 24

Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and ...
Healio

Tralokinumab shows promise as long-term treatment for head, neck atopic dermatitis

Please provide your email address to receive an email when new articles are posted on . IGA 0/1 was reached by 59% and 53% of dupilumab-naïve and dupilumab-experienced patients, respectively, at 9 ...
Seeking Alpha

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

Primary efficacy and safety results from these ongoing pivotal studies have been previously reported: https://rb.gy/oqscek. "Despite taking steps to manage their condition, many patients with atopic ...
WREG

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

NORTH CHICAGO, Ill., Sept. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The ...